Sharad K. Verma

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations

Medicine, Molecular Genetics, Oncology +15

EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

Wendy Béguelin, Relja Popovic, Matt Teater et al. · Cancer Cell · 2013 · 841 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

Stephen C. Mack, Hendrik Witt, Rosario M. Piro et al. · Nature · 2014 · 622 citations · Full text

Life Sciences, Genetics, Oncology +11

Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2

Sharad K. Verma, Xinrong Tian, Louis V. LaFrance et al. · ACS Medicinal Chemistry Letters · 2012 · 376 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +15

Cutaneous neurofibromas

Nicolás Ortonne, P. Wolkenstein, Jaishri O. Blakeley et al. · Neurology · 2018 · 112 citations · Full text

Medicine, Dermatology, Pathology +14